Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT04014205

A Phase I/II Multicenter, Open-Label, Study of a Novel Bruton s Tyrosine Kinase Inhibitor, Orelabrutinib, in Patients with B-Cell Malignancies

Status

Open

Conditions

Other

Phases

II

Age Group

Adult

Main Investiagtor

Norkin, Maxim

Practice

Lymphoma

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT04014205

Secondary Trial ID Number

ICP-CL-00107

Keywords

Treatment